Liao and colleagues (2018) showed it's significantly more stable than ascorbic acid while still being effective
The KEYNOTE A60 is a multicenter, open-label phase Ib/IIa study of efineptakin alfa (NT-I7, a long-acting IL-7 agonist) in combination with pembrolizumab in patients with refractory advanced solid tumors (NCT04332653)
This 28-day clock starts from the very first puncture
Mulyatno KC, Yamanaka A, Ngadino, Konishi E
The commonly studied oral glutathione dosage ranges from 250 to 500 mg per day
aeruginosa and Neisseria meningitidis have only been identified through virtual screening and an in vitro growth assay, which were capable of blocking the oxidation of haem at concentrations in excess of that available to pathogens in the respiratory tract (Furci et al., 2007)